NRX Pharmaceuticals's market cap is currently $72.50M. The company's EPS TTM is $-0.98; its P/E ratio is -1.36; NRX Pharmaceuticals is scheduled to report earnings on August 18, 2025, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
